Clinical Trials · NCT06401447
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Fudan University
- Enrollment
- 50
- Start date
- Dec 2023
- Locations
- 1 site, China
- Primary endpoint
- Progression Free Survival